Subscribe

R. Donald Harvey, PharmD, FCCP, BCOP

PharmD, FCCP, BCOP

Assistant Professor, Department of Hematology and Medical Oncology, and Director, Phase 1 Clinical Trials Section, Winship Cancer Institute of Emory University, Atlanta, GA

Authored Items

Carfilzomib-Based Therapies for Multiple Myeloma: A Pharmacist’s Perspective
By R. Donald Harvey, PharmD, FCCP, BCOP
Web Exclusives
Novel therapies for patients with multiple myeloma (MM) continue to show improved outcomes for a population that as little as 8 years ago had few options.

Subscribe Today!

To sign up for our newsletter or print publications, please enter your contact information below.

I'd like to receive:

Sign Up for The Oncology Nurse®‑APN/PA

Subscribe to receive the free, TON print publication, and TON Bi-Weekly e‑newsletter.

Subscribe

Amplity

© Amplity, Inc. All Rights Reserved. Privacy Policy.